(Reuters) – Europe’s medicines regulator said on Tuesday it had approved additional manufacturing sites to increase production capacity of mRNA COVID-19 vaccines developed by Pfizer-BioNTech and Moderna for the region.
The recommendations do not require a decision by the European Commission and the sites can become operational immediately, the European Medicines Agency said.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Sriraj Kalluvila)
